Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Issue 7 (14th April 2019)
- Record Type:
- Journal Article
- Title:
- Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Issue 7 (14th April 2019)
- Main Title:
- Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III
- Authors:
- Nerpin, Elisabet
Olivieri, Mario
Gislason, Thorainn
Olin, Anna C.
Nielsen, Rune
Johannessen, Ane
Ferreira, Diogenes S.
Marcon, Alessandro
Cazzoletti, Lucia
Accordini, Simone
Pin, Isabelle
Corsico, Angelo
Demoly, Pascal
Weyler, Joost
Nowak, Dennis
Jõgi, Rain
Forsberg, Bertil
Zock, Jan P.
Sigsgaard, Torben
Heinric, Joachim
Bono, Roberto
Leynaert, Bénédicte
Jarvis, Deborah
Janson, Christer
Malinovschi, Anderi - Abstract:
- Abstract: Introduction: The fractional exhaled nitric oxide (FE NO) is a marker for type 2 inflammation used in diagnostics and management of asthma. In order to use FE NO as a reliable biomarker, it is important to investigate factors that influence FE NO in healthy individuals. Men have higher levels of FE NO than women, but it is unclear whether determinants of FE NO differ by sex. Objective: To identify determinants of FE NO in men and women without lung diseases. Method: Fractional exhaled nitric oxide was validly measured in 3881 healthy subjects that had answered the main questionnaire of the European Community Respiratory Health Survey III without airways or lung disease. Results: Exhaled NO levels were 21.3% higher in men compared with women P < 0.001. Being in the upper age quartile (60.3‐67.6 years), men had 19.2 ppb (95% CI: 18.3, 20.2) higher FE NO than subjects in the lowest age quartile (39.7‐48.3 years) P = 0.02. Women in the two highest age quartiles (54.6‐60.2 and 60.3‐67.6 years) had 15.4 ppb (14.7, 16.2), P = 0.03 and 16.4 ppb (15.6, 17.1), P = <0.001 higher FE NO, compared with the lowest age quartile. Height was related to 8% higher FE NO level in men ( P < 0.001) and 5% higher FE NO levels in women ( P = 0.008). Men who smoked had 37% lower FE NO levels and women had 30% lower levels compared with never‐smokers ( P < 0.001 for both). Men and women sensitized to both grass and perennial allergens had higher FE NO levels compared withAbstract: Introduction: The fractional exhaled nitric oxide (FE NO) is a marker for type 2 inflammation used in diagnostics and management of asthma. In order to use FE NO as a reliable biomarker, it is important to investigate factors that influence FE NO in healthy individuals. Men have higher levels of FE NO than women, but it is unclear whether determinants of FE NO differ by sex. Objective: To identify determinants of FE NO in men and women without lung diseases. Method: Fractional exhaled nitric oxide was validly measured in 3881 healthy subjects that had answered the main questionnaire of the European Community Respiratory Health Survey III without airways or lung disease. Results: Exhaled NO levels were 21.3% higher in men compared with women P < 0.001. Being in the upper age quartile (60.3‐67.6 years), men had 19.2 ppb (95% CI: 18.3, 20.2) higher FE NO than subjects in the lowest age quartile (39.7‐48.3 years) P = 0.02. Women in the two highest age quartiles (54.6‐60.2 and 60.3‐67.6 years) had 15.4 ppb (14.7, 16.2), P = 0.03 and 16.4 ppb (15.6, 17.1), P = <0.001 higher FE NO, compared with the lowest age quartile. Height was related to 8% higher FE NO level in men ( P < 0.001) and 5% higher FE NO levels in women ( P = 0.008). Men who smoked had 37% lower FE NO levels and women had 30% lower levels compared with never‐smokers ( P < 0.001 for both). Men and women sensitized to both grass and perennial allergens had higher FE NO levels compared with non‐sensitized subjects 26% and 29%, P < 0.001 for both. Conclusion and Clinical Relevance: Fractional exhaled nitric oxide levels were higher in men than women. Similar effects of current smoking, height, and IgE sensitization were found in both sexes. FE NO started increasing at lower age in women than in men, suggesting that interpretation of FE NO levels in adults aged over 50 years should take into account age and sex. … (more)
- Is Part Of:
- Clinical & experimental allergy. Volume 49:Issue 7(2019)
- Journal:
- Clinical & experimental allergy
- Issue:
- Volume 49:Issue 7(2019)
- Issue Display:
- Volume 49, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 49
- Issue:
- 7
- Issue Sort Value:
- 2019-0049-0007-0000
- Page Start:
- 969
- Page End:
- 979
- Publication Date:
- 2019-04-14
- Subjects:
- fractional exhaled nitric oxide -- healthy population -- IgE sensitization -- smoking
Allergy -- Periodicals
Immunology -- Periodicals
616.97 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0954-7894&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2222 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cea.13394 ↗
- Languages:
- English
- ISSNs:
- 0954-7894
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.249700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11000.xml